본문 바로가기
주메뉴 바로가기

Korean Healthcare Industry

home >Korean Healthcare Industry >R&D Infrastructure in Biotechnology

R&D Infrastructure in Biotechnology

Biotechnology R&D Investment Performance (’94 ~ ’07)

(US$ Mill)

  • Investment
  • Growth Rate
  • ‘94

    66.768.8%
  • ‘95

    112.636.1%
  • ‘96

    153.3-16.7%
  • ‘97

    127.7-37.4%
  • ‘98

    79.969.3%
  • ‘99

    135.360.9%
  • ‘00

    217.734.9%
  • ‘01

    293.722.6%
  • ‘02

    360.123.5%
  • ‘03

    444.918.2%
  • ‘04

    52625.0%
  • ‘05

    657.731.7%
  • ‘06

    865.99.3%
  • ‘07

    946.3

Source : Journal of Korean Soclety of Medical Informatics 2009, 15(3):321-340)

  • New drug R&D projects have been briskly undertaken in fields of Cancer, Central Nervous System and Immune System Disease.
  • Most of the projects are in discovery and preclinical stage
  • Developments by Therapeutic Categories

    • Anti Cancer
    • CNS
    • Antibiotics
    • Antiviral
    • Cardiovascular
    • Liver Disease
    • Others
  • New Drug Development by Stage

    • Predinical
    • PhaseⅠ
    • PhaseⅡ
    • PhaseⅢ
    • Market Launched
    • Discovery

Source: KDRA, Korea Drug Research Association 2006

Biotechnology & NSC theses Performance(’94 ~ ’07)

  • ‘94

    0420
  • ‘95

    2933
  • ‘96

    11,343
  • ‘97

    31,479
  • ‘98

    21,820
  • ‘99

    72,137
  • ‘00

    52,495
  • ‘01

    112,651
  • ‘02

    112,875
  • ‘03

    113,297
  • ‘04

    103,894
  • ‘05

    234,089
  • ‘06

    004,539
  • ‘07

    194,909

Source : Biotech Policy Research Center 2008

Clinical Trials & Foreign Investment

  • Clincial trials have surged up after KFDA accepted IND(Investigational New Drug) program in 2002, which allows conducting clinical trials without item and manafacturing approval
  • MCTs by global pharmaceutical companies have been increasing continuously at 45% CAGR since 2002
  • 218 clinical trials were conducted in 2006, 108 of them were MCT
  • Sound environment for clinical triasls
    • Large scale hospitals near urban areas : very efficient and convenient to recruit trial subject
    • High quality medical doctors
    • Advanced IT infrastructure for clinical data namagement (EMR)
  • Number of Clinical Trials

    • 2000

      33
    • 2001

      45
    • 2002

      55
    • 2003

      143
    • 2004

      136
    • 2005

      185
    • 2006

      218
  • MCTs by Phase (2006)

    • PMS

    • PhaseⅢ

    • PhaseⅡ

    • PhaseⅠ

Source : KDRA, KOTRA